Publicaciones en colaboración con investigadores/as de Istituto per lo Studio e la Prevenzione Oncologica (280)

2024

  1. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

    The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307

  2. Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 4, pp. 558-568

2022

  1. Meat Intake Is Associated with a Higher Risk of Ulcerative Colitis in a Large European Prospective Cohort Studyø

    Journal of Crohn's & colitis, Vol. 16, Núm. 8, pp. 1187-1196

2021

  1. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study

    International Journal of Cancer, Vol. 148, Núm. 3, pp. 609-625

2019

  1. Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 144, Núm. 2, pp. 240-250

  2. Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study

    Clinical Gastroenterology and Hepatology, Vol. 17, Núm. 7, pp. 1323-1331.e6

2018

  1. A prospective evaluation of plasma polyphenol levels and colon cancer risk

    International Journal of Cancer, Vol. 143, Núm. 7, pp. 1620-1631

  2. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study

    International Journal of Cancer, Vol. 142, Núm. 7, pp. 1332-1342

  3. Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study

    BMJ (Online), Vol. 361

  4. Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk: Results from the EPIC cohort

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 790-804

  5. Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: A mendelian randomization analysis

    JAMA Cardiology, Vol. 3, Núm. 7, pp. 619-627

  6. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

    International Journal of Cancer, Vol. 142, Núm. 6, pp. 1189-1201

  7. Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort

    International Journal of Cancer, Vol. 143, Núm. 10, pp. 2437-2448

  8. Dietary intake of total polyphenol and polyphenol classes and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    European Journal of Epidemiology, Vol. 33, Núm. 11, pp. 1063-1075

  9. Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort

    International Journal of Cancer, Vol. 142, Núm. 7, pp. 1355-1360

  10. Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer

    International Journal of Cancer, Vol. 143, Núm. 2, pp. 245-252

  11. Results from the European prospective investigation into cancer and nutrition link vitamin B6 catabolism and lung cancer risk

    Cancer Research, Vol. 78, Núm. 1, pp. 302-308

2017

  1. Added value of serum hormone measurements in risk prediction models for breast cancer for women not using exogenous hormones: Results from the EPIC cohort

    Clinical Cancer Research, Vol. 23, Núm. 15, pp. 4181-4189

  2. Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort

    International Journal of Cancer, Vol. 140, Núm. 6, pp. 1246-1259

  3. Circulating RANKL and RANKL/OPG and breast cancer risk by ER and PR subtype: Results from the EPIC cohort

    Cancer Prevention Research, Vol. 10, Núm. 9, pp. 525-534